Acadia gets Health Canada approval for Daybue to treat Rett Syndrome
Daybue is a synthetic analog of the N-terminal tripeptide of insulin-like growth factor 1, indicated for the treatment of Rett Syndrome in adults and children, aged two years and above,...
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry